Radiopharmaceuticals for Diagnostics an Therapy

Radiopharmaceuticals for Diagnostics an Therapy

Pharmaceutical Products, Prescriptions

Information

We produce radiopharmaceuticals in six highly specialized GMP cleanroom laboratories with a total area of 400 m² at our site in Seibersdorf, Austria, one of the leading radiopharmaceutical production sites in Europe. As a European radiopharmaceutical CDMO, we support both clinical development programs and commercial manufacturing, offering pharmaceutical companies a reliable production partner with short decision-making processes and fast time-to-market implementation. Product & Service Portfolio Our radiopharmaceutical CDMO services in Europe: • Radiolabeling of small molecules, peptides, and antibodies • Formulation and stabilization of radiopharmaceutical active ingredients • Aseptic filling under GMP conditions • Packaging and release processes in accordance with European and international regulatory requirements Our products: • Investigational medicinal products (Phase I–III) for early and late development phases • Commercial radiopharmaceuticals for the European and international markets Our current focus is on diagnostic and therapeutic radiopharmaceuticals (theranostics) using the radionuclides fluorine-18 (F-18) for PET diagnostics, lutetium-177 (Lu-177) for targeted radionuclide therapy, and actinium-225 (Ac-225) for alpha-therapeutic applications in oncology.

Log in

See all the content and easy-to-use features by logging in or registering!